NOVADEL PHARMA INC
CIK 0001043873
Revenue (TTM)
$439K
Q3 Oct 2011
Net Income (TTM)
−$6.29M
Q3 Oct 2011
EPS Diluted (TTM)
—
Q3 Oct 2011
Gross Margin
—
Q3 Oct 2011
Operating Margin
-1,038.5%
Q3 Oct 2011
Net Margin
-1,431.7%
Q3 Oct 2011
Free Cash Flow (TTM)
—
Q3 Oct 2011
Cash
$429K
Q3 Oct 2011
Total Debt
—
Q3 Oct 2011
Shares Outstanding
134.89M sh
Q3 Oct 2011